Loreana Silveira

Dr. Loreana Silveira

Institute of Biomedical Sciences, University of Sao Paulo
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2017 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
CSCamila Oliveira de Souza
Camila Oliveira de Souza
ATAlexandre As Teixeira
Alexandre As Teixeira
LBLuana Amorim Biondo
Luana Amorim Biondo
Loreana SilveiraLoreana Silveira
Loreana Silveira
PCPhilip Calder
Philip Calder
JNJosé Cesar Rosa Neto
José Cesar Rosa Neto

1 January 2016 in Critical Reviews™ in Eukaryotic Gene Expression
Verified
Journal Article
Closed access
PDF file
Loreana SilveiraLoreana Silveira
Loreana Silveira
BABarbara Moura Antunes
Barbara Moura Antunes
AMAndre Luis Araujo Minari
Andre Luis Araujo Minari
RSRonaldo Vagner Thomatieli dos Santos
Ronaldo Vagner Thomatieli dos Santos
JNJosé Cesar Rosa Neto
José Cesar Rosa Neto
FLFábio Santos Lira
Fábio Santos Lira
Macrophages are cells of the innate immune response that trigger inflammation resolution. The phenotype of "classically activated macrophages" (M1) has anti-tumoricidal and anti-bactericidal activities. On the other hand, "alternatively activated macrophages" (M2) are involved in tissue remodeling and immunomodulatory functions. The change in the polarization of macrophages varies according to the diversity of cytokines present in the microenvironment or by the stimuli of an antigen. It involves such factors as interferon-regulatory factors, peroxisome proliferator-activated receptors (PPARs), hypoxia-inducible factors (HIFs), and signal transducers and activators of transcription (STATs). Switching the phenotype of macrophages can help attenuate the development of an inflammatory disease. Exercise can promote alterations in the number of innate immune cells and stimulates phagocytic function. Chronic exercise seems to inhibit macrophage infiltration into adipose tissue by attenuating the expression of F4/80 mRNA. Furthermore, exercise may also increase the expression of M2 markers and reduce TNF-α and TLR4 mRNA expression, which activates the inflammatory pathway of NF-κB. Chronic exercise reduces β2-adrenergic receptors in monocytes and macrophages by modulating TLR4 signaling as well as suppressing IL-12 production, a stimulator of interferon Y. In this review, we discuss macrophage polarization in metabolic diseases and how exercise can modulate macrophage plasticity.

Verified
Journal Article
Open access
PDF file
JNJosé Cesar Rosa Neto
José Cesar Rosa Neto
PCPhilip Calder
Philip Calder
RCRui Curi
Rui Curi
Philip NewsholmePhilip Newsholme
Philip Newsholme
JSJaswinder K. Sethi
Jaswinder K. Sethi
Loreana SilveiraLoreana Silveira
Loreana Silveira
Macrophages and lymphocytes demonstrate metabolic plasticity, which is dependent partly on their state of activation and partly on the availability of various energy yielding and biosynthetic substrates (fatty acids, glucose, and amino acids). These substrates are essential to fuel-based metabolic reprogramming that supports optimal immune function, including the inflammatory response. In this review, we will focus on metabolism in macrophages and lymphocytes and discuss the role of fatty acids in governing the phenotype, activation, and functional status of these important cells. We summarize the current understanding of the pathways of fatty acid metabolism and related mechanisms of action and also explore possible new perspectives in this exciting area of research.

7 August 2013 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
Loreana SilveiraLoreana Silveira
Loreana Silveira
PMPaula Alves Monteiro
Paula Alves Monteiro
BABarbara Moura Antunes
Barbara Moura Antunes
PSPatrícia Monteiro Monteiro Seraphim
Patrícia Monteiro Monteiro Seraphim
RFRômulo Araújo Fernandes
Rômulo Araújo Fernandes
IJIsmael F F F Freitas Júnior
Ismael F F F Freitas Júnior
Previous studies have shown an association between adiposity, especially intra-abdominal adipose tissue, and hemodynamic/metabolic comorbidities in adults, however it is not clear in pediatric population. The aim of the study was to analyze the relationship between non-alcoholic fatty liver disease (NAFLD) and components of metabolic syndrome (MS) with values of intra-abdominal (IAAT) and subcutaneous (SCAT) adipose tissue in obese children and adolescents.

1 October 2020 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Open access
CSCamila O. Souza
Camila O. Souza
ATAlexandre A.S. Teixeira
Alexandre A.S. Teixeira
LBLuana Amorim Biondo
Luana Amorim Biondo
Loreana SilveiraLoreana Silveira
Loreana Silveira
CBCristiane N. de Souza Breda
Cristiane N. de Souza Breda
JNJosé Cesar Rosa Neto
José Cesar Rosa Neto
Palmitoleic acid (POA, 16:1n-7) is a lipokine that has potential nutraceutical use to treat non-alcoholic fatty liver disease. We tested the effects of POA supplementation (daily oral gavage, 300 mg/Kg, 15 days) on murine liver inflammation induced by a high fat diet (HFD, 59% fat, 12 weeks). In HFD-fed mice, POA supplementation reduced serum insulin and improved insulin tolerance compared with oleic acid (OA, 300 mg/Kg). The livers of POA-treated mice exhibited less steatosis and inflammation than those of OA-treated mice with lower inflammatory cytokine levels and reduced toll-like receptor 4 protein content. The anti-inflammatory effects of POA in the liver were accompanied by a reduction in liver macrophages (LM, CD11c+; F4/80+; CD86+), an effect that could be triggered by peroxisome proliferator activated receptor (PPAR)-γ, a lipogenic transcription factor upregulated in livers of POA-treated mice. We also used HFD-fed mice with selective deletion of PPAR-γ in myeloid cells (PPAR-γ KOLyzCre+) to test whether the beneficial anti-inflammatory effects of POA are dependent on macrophages PPAR-γ. POA-mediated improvement of insulin tolerance was tightly dependent on myeloid PPAR-γ, while POA anti-inflammatory actions including the reduction in liver inflammatory cytokines were preserved in mice bearing myeloid cells deficient in PPAR-γ. This overlapped with increased CD206+ (M2a) cells and downregulation of CD86+ and CD11c+ liver macrophages. Moreover, POA supplementation increased hepatic AMPK activity and decreased expression of the fatty acid binding scavenger receptor, CD36. We conclude that POA controls liver inflammation triggered by fat accumulation through induction of M2a macrophages independently of myeloid cell PPAR-γ.

1 November 2012 in The Journal of Pediatrics
Verified
Journal Article
Closed access
IJIsmael F. Freitas Júnior
Ismael F. Freitas Júnior
Diego ChristofaroDiego Christofaro
Diego Christofaro
JCJamile S. Codogno
Jamile S. Codogno
PMPaula A. Monteiro
Paula A. Monteiro
Loreana SilveiraLoreana Silveira
Loreana Silveira
RFRômulo A. Fernandes
Rômulo A. Fernandes